Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis.

Francisco G, Menezes PR, Eluf-Neto J, Chammas R.

Eur J Hum Genet. 2008 Jun;16(6):724-34. doi: 10.1038/ejhg.2008.6.

2.

Associations between XPC polymorphisms and risk of cancers: A meta-analysis.

Qiu L, Wang Z, Shi X, Wang Z.

Eur J Cancer. 2008 Oct;44(15):2241-53. doi: 10.1016/j.ejca.2008.06.024. Review.

PMID:
18771913
3.

Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.

Zheng W, Cong XF, Cai WH, Yang S, Mao C, Zou HW.

Breast Cancer Res Treat. 2011 Aug;128(3):811-5. doi: 10.1007/s10549-011-1369-6.

PMID:
21318603
4.

A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk.

Zhang D, Chen C, Fu X, Gu S, Mao Y, Xie Y, Huang Y, Li Y.

J Hum Genet. 2008;53(1):18-33.

PMID:
18097734
5.

Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.

He J, Shi TY, Zhu ML, Wang MY, Li QX, Wei QY.

Int J Cancer. 2013 Oct 15;133(8):1765-75. doi: 10.1002/ijc.28089.

6.

DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies.

Han S, Zhang HT, Wang Z, Xie Y, Tang R, Mao Y, Li Y.

Eur J Hum Genet. 2006 Oct;14(10):1136-44.

7.

Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.

Zhu Y, Lai M, Yang H, Lin J, Huang M, Grossman HB, Dinney CP, Wu X.

Carcinogenesis. 2007 Mar;28(3):698-703.

PMID:
17052994
8.

DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies.

Wang F, Chang D, Hu FL, Sui H, Han B, Li DD, Zhao YS.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):507-17. doi: 10.1158/1055-9965.EPI-07-2507.

9.

Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.

Li C, Hu Z, Liu Z, Wang LE, Strom SS, Gershenwald JE, Lee JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, Duvic M, Grimm EA, Wei Q.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2526-32.

10.

Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk.

Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2537-41.

11.

XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.

Liu C, Yin Q, Ying M, Lin J, Li L, Jiao G, Wang M, Wang Y.

Mol Biol Rep. 2014 Feb;41(2):1171-8. doi: 10.1007/s11033-013-2964-x.

PMID:
24385304
12.

XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis.

Wang C, Sun Y, Han R.

Urology. 2008 Oct;72(4):869-72. doi: 10.1016/j.urology.2007.12.059.

PMID:
18336890
13.

MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.

Mao C, Qiu LX, Zhan P, Xue K, Ding H, Du FB, Li J, Chen Q.

J Cancer Res Clin Oncol. 2010 Jul;136(7):975-9. doi: 10.1007/s00432-009-0742-x.

PMID:
20012093
14.

Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis.

Wang S, Wang F, Shi X, Dai J, Peng Y, Guo X, Wang X, Shen H, Hu Z.

Eur J Cancer. 2009 Nov;45(16):2874-81. doi: 10.1016/j.ejca.2009.04.024. Review.

PMID:
19467856
15.

XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.

Dai QS, Hua RX, Zeng RF, Long JT, Peng ZW.

Tumour Biol. 2014 Jan;35(1):447-53. doi: 10.1007/s13277-013-1062-y.

PMID:
23918308
16.

MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population.

Miyaishi A, Osawa K, Osawa Y, Inoue N, Yoshida K, Kasahara M, Tsutou A, Tabuchi Y, Sakamoto K, Tsubota N, Takahashi J.

J Exp Clin Cancer Res. 2009 Jan 22;28:10. doi: 10.1186/1756-9966-28-10.

17.
18.

XPC Polymorphism Increases Risk of Digestive System Cancers: Current Evidence from A Meta-Analysis.

Jiang X, Zhou LT, Zhang SC, Chen K.

Chin J Cancer Res. 2012 Sep;24(3):181-9. doi: 10.1007/s11670-012-0181-0.

19.

XRCC1 polymorphism and lung cancer risk.

Schneider J, Classen V, Helmig S.

Expert Rev Mol Diagn. 2008 Nov;8(6):761-80. doi: 10.1586/14737159.8.6.761. Review.

PMID:
18999926
20.

Ala499Val (C>T) and Lys939Gln (A>C) polymorphisms of the XPC gene: their correlation with the risk of primary gallbladder adenocarcinoma--a case-control study in China.

Jiao X, Ren J, Chen H, Ma J, Rao S, Huang K, Wu S, Fu J, Su X, Luo C, Shi J, Broelsch CE.

Carcinogenesis. 2011 Apr;32(4):496-501. doi: 10.1093/carcin/bgq250.

PMID:
21113018

Supplemental Content

Support Center